Adrianus Jonathan, MD, MRes

MD @Medicine_UI | MRes @NewcastleMedSchool | IMG from 🇮🇩 | AAMC ID: 16092642 | Aspiring cardiologist and huge @ManUtd fan

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

Hi #MedTwitter ! I’m Adrianus Jonathan, an Indonesian 🇮🇩 #IMG. Thrilled to be applying for #InternalMedicine in this #Match2025

Passionate about ⚽️, also an avid cinephile 🎬 and foodie 🍕🍜

Excited to connect with fellow applicants & mentors!

@Inside_TheMatch @StoriesImg

[isa @abbotprofen]

OH MY GOD THIS IS SO COOL a real life ER doctor gathered patients' charts from the show with clinical timelines, differential diagnosis, medical decisions, and clinical pearls.

thank you so much Dr. Saidi i'm so using this for my ER rotations next year 🥹
https://t.co/afcGtdBLhV

[Dr Ihab Suliman @IhabFathiSulima]

🚨 10 striking conclusions from ESC 2026

1. HFmrEF is essentially gone.
ESC now defines HFrEF as LVEF <50% and HFpEF as ≥50%.

2. MRAs have broken the EF barrier.
Mineralocorticoid receptor antagonists now have a Class I recommendation in chronic HF irrespective of LVEF. Semaglutide/tirzepatide receive Class IIa recommendations for HFpEF with obesity.

3. SINGLE-AF: anticoagulation may start earlier than we thought.
In AF patients at intermediate stroke risk, DOAC therapy reduced adverse clinical outcomes by 69% versus no anticoagulation.

4. Severe TR is no longer just “give diuretics and watch.”
TRIC-I-HF: transcatheter tricuspid repair reduced HF hospitalisation and all-cause mortality compared with medical therapy alone.

5. Unexplained syncope deserves early prolonged ECG monitoring.
ASPIRED: immediate 14-day monitoring did not prevent recurrent syncope, but substantially improved arrhythmia diagnosis/treatment and was associated with lower mortality.

6. Intermediate–high-risk PE may be entering the catheter era.
PRAGUE-26: catheter-directed thrombolysis improved short-term clinical outcomes versus anticoagulation alone, without an obvious major bleeding penalty.

7. Cardiac arrest + no STEMI ≠ automatic immediate cath lab.
DISCO: immediate angiography after OHCA without ST elevation did not improve 30-day survival.

8. Being ≥70 is not a reason to abandon primary-prevention statins.
STAREE: atorvastatin reduced major cardiovascular events by about 30% in older adults without known CVD, although disability-free survival was unchanged.

9. AF ablation has a surprisingly large placebo component for symptoms.
PVI-SHAM-AF: ablation reduced AF recurrence, yet improvement in AF-related quality of life was not significantly greater than sham treatment.

10. Even the definition of MI has changed.
The 5th Universal Definition of MI replaces the traditional numbered framework with primary MI, secondary MI and procedure-related MI, while incorporating sex-specific troponin thresholds and greater use of imaging.

🔥 The one-line ESC 2026 message:

Treat HF across the EF spectrum, anticoagulate selected AF patients earlier, intervene on TR, monitor syncope sooner—and stop rushing every post-arrest patient without STEMI to the cath lab.

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

@AsudaniMarish [email protected]

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

@marco_tahir stay safe brother 🙏🏻

[Malke Asaad @malkeasaad]

The EHR module by ECFMG is out! Don’t miss it out

All IMGs who matched to a 2025 first-year residency position in a U.S. training program are eligible to use the learning module once their matched status is confirmed

The module will be available from May 5, 2025 through 11:59 p.m. on June 30, 2025, U.S. Eastern Time.

https://t.co/Np1D1DUN30

[Letterboxd @letterboxd]

The Secret Life of Walter Mitty (2013) ✨

[Michael Justus @mhjrad]

There's a new type of diabetes (type 5)

[NRMP® @TheNRMP]

The Rank Order List Certification Deadline for the 2025 Main Residency Match is tomorrow, Wednesday, March 5, at 9 pm ET. Your rank order list must be certified at this time.

Good luck to all #Match2025 participants!

#MedEd #ROL #RankOrderList #NRMP

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

@Wood_Jester dah ntn semua lu?

[AHA Science @AHAScience]

The 2025 ACS guideline synthesizes new evidence since the 2013 STEMI and 2014 NSTEMI guidelines and the 2015 focused update on primary PCI in STEMI.

This guideline was developed with @ACCInTouch in collaboration with and endorsed by @EmergencyDocs @NAEMSP @SCAI

[Dr Ahmad Rehan Khan @AhmadRehanKhan]

𝗠𝗮𝘁𝗰𝗵 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝗻𝘁𝘀: 𝗨 𝗚𝗼𝘁 𝗧𝗵𝗶𝘀
Almost 31 days until you find out the Match Result.
✅ You Will Match ✅
✅ Don't Worry ✅
✅ You Got this ✅

#Match2025 #MedTwitter #MedEd

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

@Wood_Jester bcs our lives already jokes bruh wkwkw :(

[Adrianus Jonathan, MD, MRes @AJSugiharta_MD]

@Wood_Jester jadi critanyaa.. lu bakalan ons with someone and he/she/them would moan louder than bombs and you’d feel like dying bcs of it.. but it turned out that it was all just a dream when ur mom called

[Dr Ahmad Rehan Khan @AhmadRehanKhan]

𝗠𝗼𝘃𝗲 𝗨𝗦𝗠𝗟𝗘 𝗦𝘁𝗲𝗽 𝟯 𝘁𝗼 𝗽𝗮𝘀𝘀-𝗳𝗮𝗶𝗹 𝘁𝗼 𝗯𝗼𝗼𝘀𝘁 𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁𝘀’ 𝘄𝗲𝗹𝗹-𝗯𝗲𝗶𝗻𝗴:

AMA is advocating for the following changes to USMLE Step 3:

1) Changing the USMLE Step 3 and COMLEX-USA Level 3 from a numerically scored examination to a pass-fail examination.

2) Changing USMLE Step 3 and COMLEX-USA Level 3 from a two-day examination to a one-day examination.

3) The option to take USMLE Step 3 after passing Step 2 Clinical Knowledge (CK), or take COMLEX-USA Level 3 after passing Level 2-Cognitive Evaluation (CE) during medical school.

4) Residents taking the USMLE Step 3 or COMLEX-USA Level 3 exam be allowed days off to take the exam without having this time counted for paid time off or vacation balance

https://t.co/GfdiEJkcZx

#Match2025 #MedTwitter #MedEd
#USMLEStep3 #InsideTheMatch #IMGs #ECFMG #NRMP #ERAS
#AmericanMedicalAssociation

[Dr Ahmad Rehan Khan @AhmadRehanKhan]

𝐅𝐢𝐫𝐬𝐭 𝐃𝐫𝐮𝐠 𝐟𝐨𝐫 𝐎𝐛𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐯𝐞 𝐒𝐥𝐞𝐞𝐩 𝐀𝐩𝐧𝐞𝐚
FDA approved Zepbound (tirzepatide) for the treatment of moderate to severe OSA in adults with obesity, to be used in combination with a reduced-calorie diet.

https://t.co/WaMlrbwaSB

#tirzepatide #OSA #MedEd #MedTwitter #sleep #MedX

[Oren Gottfried, MD @OGdukeneurosurg]

Anatomy help

[NRMP® @TheNRMP]

Want to know the ins and outs of the matching algorithm and how it works?

Hint - it's not magic. Check out this short video: https://t.co/xd0E27Suro.

#Match2025 #ResidencyMatch #IMG #MedStudent #MedEd #NRMP

[Saad Ur Rahman @SaadUrRahman55]

Takeaways from #AHA2024. Late breaking trials - take home points
@AHAScience

1. BPROAD Trial: Intensive treatment targeting SBP ≤120 mmHg reduced the incidence of MACE at 5 years vs. standard treatment targeting ≤140 mmHg in patients with type 2 diabetes and hypertension with elevated CV risk.

[Dear Son. @DearS_o_n]

Dear son,

[Malke Asaad @malkeasaad]

🚨🚨Amazing news! The application for the Tennessee pathway is now OPEN! IMGs can now apply to practice in Tennessee without doing any clinical training in the U.S. 🇺🇸 Get the application link from our blog here https://t.co/ftnGyWCkS4